BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 20660310)

  • 1. Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis.
    Henderson WR; Chi EY; Ye X; Nguyen C; Tien YT; Zhou B; Borok Z; Knight DA; Kahn M
    Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14309-14. PubMed ID: 20660310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
    Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
    [No Abstract]   [Full Text] [Related]  

  • 3. Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis.
    Kim TH; Kim SH; Seo JY; Chung H; Kwak HJ; Lee SK; Yoon HJ; Shin DH; Park SS; Sohn JW
    Tohoku J Exp Med; 2011 Jan; 223(1):45-54. PubMed ID: 21212602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP).
    Zhou B; Liu Y; Kahn M; Ann DK; Han A; Wang H; Nguyen C; Flodby P; Zhong Q; Krishnaveni MS; Liebler JM; Minoo P; Crandall ED; Borok Z
    J Biol Chem; 2012 Mar; 287(10):7026-38. PubMed ID: 22241478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Wnt/β-catenin signaling suppresses myofibroblast differentiation of lung resident mesenchymal stem cells and pulmonary fibrosis.
    Cao H; Wang C; Chen X; Hou J; Xiang Z; Shen Y; Han X
    Sci Rep; 2018 Sep; 8(1):13644. PubMed ID: 30206265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis.
    Hao S; He W; Li Y; Ding H; Hou Y; Nie J; Hou FF; Kahn M; Liu Y
    J Am Soc Nephrol; 2011 Sep; 22(9):1642-53. PubMed ID: 21816937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation.
    Teo JL; Ma H; Nguyen C; Lam C; Kahn M
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12171-6. PubMed ID: 16093313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
    Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM
    Oncogene; 2014 Apr; 33(17):2169-78. PubMed ID: 23728349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective targeting of CREB-binding protein/β-catenin inhibits growth of and extracellular matrix remodelling by airway smooth muscle.
    Koopmans T; Crutzen S; Menzen MH; Halayko AJ; Hackett TL; Knight DA; Gosens R
    Br J Pharmacol; 2016 Dec; 173(23):3327-3341. PubMed ID: 27629364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12.
    Akcora BÖ; Storm G; Bansal R
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):804-818. PubMed ID: 29217140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
    Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
    Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Wnt/β-catenin signaling promotes epithelial differentiation of mesenchymal stem cells and repairs bleomycin-induced lung injury.
    Wang C; Zhu H; Sun Z; Xiang Z; Ge Y; Ni C; Luo Z; Qian W; Han X
    Am J Physiol Cell Physiol; 2014 Aug; 307(3):C234-44. PubMed ID: 24898581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
    Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
    Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betulinic acid attenuated bleomycin-induced pulmonary fibrosis by effectively intervening Wnt/β-catenin signaling.
    Li X; Liu X; Deng R; Gao S; Jiang Q; Liu R; Li H; Miao Y; Zhai Y; Zhang S; Wang Z; Ren Y; Ning W; Zhou H; Yang C
    Phytomedicine; 2021 Jan; 81():153428. PubMed ID: 33341025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gamma catenin/CBP complex maintains survivin transcription in β-catenin deficient/depleted cancer cells.
    Kim YM; Ma H; Oehler VG; Gang EJ; Nguyen C; Masiello D; Liu H; Zhao Y; Radich J; Kahn M
    Curr Cancer Drug Targets; 2011 Feb; 11(2):213-25. PubMed ID: 21158719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth.
    Arensman MD; Telesca D; Lay AR; Kershaw KM; Wu N; Donahue TR; Dawson DW
    Mol Cancer Ther; 2014 Oct; 13(10):2303-14. PubMed ID: 25082960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Human Airway Epithelial Tissue Stem Cell Differentiation by β-Catenin, P300, and CBP.
    Malleske DT; Hayes D; Lallier SW; Hill CL; Reynolds SD
    Stem Cells; 2018 Dec; 36(12):1905-1916. PubMed ID: 30171668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
    Chandler KB; Alamoud KA; Stahl VL; Nguyen BC; Kartha VK; Bais MV; Nomoto K; Owa T; Monti S; Kukuruzinska MA; Costello CE
    Mol Omics; 2020 Jun; 16(3):195-209. PubMed ID: 32203567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhibition of CBP-coactivated β-catenin-mediated Wnt signalling in uremic rats with vascular calcifications.
    Gravesen E; Nordholm A; Mace M; Morevati M; Høgdall E; Nielsen C; Kjær A; Olgaard K; Lewin E
    PLoS One; 2018; 13(8):e0201936. PubMed ID: 30075015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.